QTRX
What one share of Quanterix holds
Laboratory Analytical Instruments
We are a life sciences company transforming healthcare innovation by accelerating biomarker breakthroughs from discovery to diagnostics using our ultra-sensitive translational research and spatial biology instruments, consumables, and services.
Quanterix’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.28 |
|---|---|
| Profit | −$2.63 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$1.75 |
| Cash and investments | $0.94 |
| Book value | $5.03 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $8.21 | −$12.89 | $0.25 | −$8.53 | — | −$53.72 |
| 2018 | $1.71 | −$1.43 | $0.07 | −$1.37 | — | $1.84 |
| 2019 | $2.26 | −$1.63 | $0.43 | −$1.48 | — | $4.58 |
| 2020 | $2.92 | −$1.07 | $0.13 | −$0.92 | — | $6.47 |
| 2021 | $3.07 | −$1.54 | $0.38 | −$1.70 | — | $12.04 |
| 2022 | $2.85 | −$2.69 | $0.31 | −$1.63 | — | $9.60 |
| 2023 | $3.25 | −$0.75 | $0.10 | −$0.60 | — | $9.21 |
| 2024 | $3.58 | −$1.00 | $0.09 | −$1.00 | — | $8.56 |
| 2025 | $3.26 | −$2.51 | $0.06 | −$1.87 | — | $6.33 |